Abstract

Introduction: This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients. Patients and Methods: Validity and reliability of Iranian version of Coping Self-efficacy Scale (CSES) were measured by a cross-sectional study. Content validity, reliability and cultural equivalency were appraised through qualitative and quantitative study on 260 participants who have type 2 diabetes. Results: Reliability and validity of the scale and its four subscales, such as “stop unpleasant emotions and thoughts” (a = 0.92) “used problem-focused coping” (a = 0.71), Self-efficacy on diabetes problem solving (a = 0.74) and “get support from friends and family” (a = 0.67) were approved explicitly by a psychometric analysis; these show that the scale was slightly valid and reliable on the study setting. An intraclass correlation coefficient was satisfactory (p < 0.001). Criterion validity between total scale and metabolic control Index (HbA1c) of type 2 diabetic patients was significant (p < 0.001) and showed indirect correlation with the domains of the scale. Conclusion: Study findings supported the reliability and validity of the Iranian version of new Coping Self-efficacy-24 for measuring Coping Selfefficacy among Iranian type 2 diabetic patients. Based on our finding, we would like to recommend appropriate interventions in the future.

Highlights

  • This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients

  • As type 2 diabetes and its control are a big challenge among patients in their lives, we aimed to develop a valid and reliable scale with the intention of measuring Coping Self-efficacy (CSES) level of Iranian type 2 diabetes patients

  • Translated F-Coping Self-efficacy Scale (CSES)-26 was sent to 10 academic members who were expert in instrument development and type 2 diabetes management

Read more

Summary

Introduction

This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients. There are studies which represented decreasing diabetes stress can be practical with using coping strategies [11] Since, it seems that coping Self-efficacy can be one of the main points of diabetes care because of rapid prevalence and incidence of diabetes in Iran [4], a great need for a valid and reliable scale for assessing psychosocial issues and interventional studies as Chesney et al mentioned it as a specific character of the scale. As type 2 diabetes and its control are a big challenge among patients in their lives, we aimed to develop a valid and reliable scale with the intention of measuring Coping Self-efficacy (CSES) level of Iranian type 2 diabetes patients. Validation of scale which was developed by Chesney et al (2006) seems to be a requisite in Iranian setup to conduct future interventions

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call